ASCVD Risk Estimator Plus
ASO Keyword Dashboard
Tracking 75 keywords for ASCVD Risk Estimator Plus in Apple App Store
ASCVD Risk Estimator Plus tracks 75 keywords (no keywords rank yet; 75 need traction). Key metrics: opportunity 70.0, difficulty 36.7.
Tracked keywords
75
0 ranked • 75 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
70.0
Top keyword: patient
Avg difficulty
36.7
Lower scores indicate easier wins
Opportunity leaders
- 64.0
patient
Opportunity: 73.0 • Difficulty: 38.5 • Rank —
Competitors: 13
- 68.2
course
Opportunity: 73.0 • Difficulty: 41.1 • Rank —
Competitors: 64
- 66.9
monitoring
Opportunity: 73.0 • Difficulty: 40.5 • Rank —
Competitors: 50
- 65.2
impact
Opportunity: 73.0 • Difficulty: 39.7 • Rank —
Competitors: 80
- 64.8
risk
Opportunity: 73.0 • Difficulty: 39.3 • Rank —
Competitors: 46
Unranked opportunities
patient
Opportunity: 73.0 • Difficulty: 38.5 • Competitors: 13
course
Opportunity: 73.0 • Difficulty: 41.1 • Competitors: 64
monitoring
Opportunity: 73.0 • Difficulty: 40.5 • Competitors: 50
impact
Opportunity: 73.0 • Difficulty: 39.7 • Competitors: 80
risk
Opportunity: 73.0 • Difficulty: 39.3 • Competitors: 46
High competition keywords
help
Total apps: 149,354 • Major competitors: 1,307
Latest rank: — • Difficulty: 52.4
best
Total apps: 116,755 • Major competitors: 1,445
Latest rank: — • Difficulty: 51.4
using
Total apps: 115,821 • Major competitors: 805
Latest rank: — • Difficulty: 51.2
information
Total apps: 111,770 • Major competitors: 564
Latest rank: — • Difficulty: 51.0
based
Total apps: 80,200 • Major competitors: 593
Latest rank: — • Difficulty: 49.6
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| best | 66 | 100 | 51 | 85 116,755 competing apps Median installs: 100 Avg rating: 4.2 | — | — | 1,445 major competitor apps |
| change | 69 | 100 | 46 | 77 38,450 competing apps Median installs: 100 Avg rating: 4.1 | — | — | 419 major competitor apps |
| care | 70 | 100 | 45 | 75 29,383 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 270 major competitor apps |
| support | 67 | 100 | 49 | 82 74,165 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 552 major competitor apps |
| date | 69 | 100 | 47 | 77 40,190 competing apps Median installs: 50 Avg rating: 4.2 | — | — | 258 major competitor apps |
| information | 66 | 100 | 51 | 85 111,770 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 564 major competitor apps |
| management | 69 | 100 | 47 | 77 42,170 competing apps Median installs: 25 Avg rating: 4.1 | — | — | 151 major competitor apps |
| using | 66 | 100 | 51 | 85 115,821 competing apps Median installs: 75 Avg rating: 4.1 | — | — | 805 major competitor apps |
| help | 65 | 100 | 52 | 87 149,354 competing apps Median installs: 75 Avg rating: 4.2 | — | — | 1,307 major competitor apps |
| patients | 72 | 100 | 38 | 63 5,427 competing apps Median installs: 50 Avg rating: 4.2 | — | — | 18 major competitor apps |
| around | 69 | 100 | 48 | 79 50,163 competing apps Median installs: 100 Avg rating: 4.2 | — | — | 574 major competitor apps |
| patient | 73 | 100 | 38 | 64 6,660 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 13 major competitor apps |
| tool | 69 | 100 | 47 | 78 48,277 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 180 major competitor apps |
| plan | 69 | 100 | 46 | 77 37,579 competing apps Median installs: 75 Avg rating: 4.3 | — | — | 400 major competitor apps |
| plus | 72 | 100 | 43 | 70 15,026 competing apps Median installs: 100 Avg rating: 4.1 | — | — | 276 major competitor apps |
| type | 71 | 100 | 44 | 73 23,615 competing apps Median installs: 75 Avg rating: 4.1 | — | — | 170 major competitor apps |
| discussion | 71 | 100 | 33 | 55 1,906 competing apps Median installs: 50 Avg rating: 4.3 | — | — | 8 major competitor apps |
| year | 72 | 100 | 43 | 71 17,820 competing apps Median installs: 100 Avg rating: 4.2 | — | — | 210 major competitor apps |
| course | 73 | 100 | 41 | 68 11,839 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 64 major competitor apps |
| user | 68 | 100 | 49 | 81 66,432 competing apps Median installs: 50 Avg rating: 4.1 | — | — | 475 major competitor apps |
| feedback | 70 | 100 | 45 | 74 27,605 competing apps Median installs: 75 Avg rating: 4.1 | — | — | 189 major competitor apps |
| decision | 72 | 100 | 38 | 62 5,407 competing apps Median installs: 50 Avg rating: 4.2 | — | — | 37 major competitor apps |
| assessment | 72 | 100 | 36 | 59 3,531 competing apps Median installs: 25 Avg rating: 4.1 | — | — | 16 major competitor apps |
| expert | 72 | 100 | 42 | 70 14,850 competing apps Median installs: 75 Avg rating: 4.3 | — | — | 172 major competitor apps |
| guideline | 68 | 100 | 25 | 41 279 competing apps Median installs: 50 Avg rating: 4.2 | — | — | 0 major competitor apps |
App Description
Use the app to:
• Estimate a patient’s initial 10-year ASCVD risk using the pooled cohort equation
• Receive an individualized, risk-based, intervention approach
• Project the impact of specific interventions on a patient’s risk
• Guide clinician-patient discussion around customizing an intervention plan
• Update risk at follow-up based on a patient’s response to therapy using the Million Hearts Longitudinal model
Advice from the app is derived from the 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes, the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, the 2018 ACC/AHA et al. Guideline on the Management of Blood Cholesterol, the 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment, the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk, and the 2016 Million Hearts Longitudinal ASCVD Risk Assessment Tool user guide.
The information and recommendations in this clinical decision support tool are meant to support clinical decision making. They are not meant to represent the only or best course of care or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.